Institutional Knowledge Map (KMap)
Map
Services
How To Use
About
Toggle theme
Loading...
Menu
Patricia Robles Quihuis
Research Nurse III
Cancer Center Division
Map Page
Research Area
clinical trial,
oncology,
pharmacokinetics,
safety,
dose escalation,
drug combination,
efficacy,
patient safety,
prostate cancer,
treatment comparison
Grants
(4)
A Phase 3, Randomized, Open-label Study of MK-5684 versus Alternative Abiraterone Acetate or Enzalutamide in Participants with Metastatic Castration-resistant Prostate Cancer (mCRPC) That Progressed O
Active
·
2024
·
$0 / $2.2M
·
External
prostate cancer,
clinical trial,
treatment comparison,
metastatic cancer,
hormone therapy
A Phase 1b, Open-Label, Safety, Tolerability, and Efficacy Study of HC-7366 in Combination with Belzutifan (WELIREG) in Patients with Locally Advanced (Inoperable) or Metastatic Renal Cell Carcinoma
Active
·
2024
·
$0 / $625.4K
·
External
oncology,
clinical trial,
drug combination,
efficacy,
patient safety
A Phase 1/2, Open-Label, Dose-Escalation and Expansion Study of the Bruton Tyrosine Kinase-Targeted Protein-Degrader BGB-16673 in Patients With B-Cell Malignancies
Active
·
2022
·
$0 / $277.3K
·
External
cancer,
drug development,
clinical trial,
molecular biology,
oncology
A Dose Escalation and Expansion Study of the Safety and Pharmacokinetics of XL114 in Subjects with Non-Hodgkins Lymphoma
Active
·
2022
·
$0 / $236.5K
·
External
pharmacokinetics,
oncology,
clinical trial,
safety,
dose escalation
Collaborations
(12)
Hina Arif Tiwari
Mutual work: 2 Proposals
Collaboration Details
Michele Chu-Pilli
Mutual work: 3 Proposals﹒2 Grants
Collaboration Details
Edward Gelmann
Mutual work: 2 Proposals﹒2 Grants
Collaboration Details
Bital Savir-Baruch
Mutual work: 2 Proposals
Collaboration Details
Brianna Denton
Mutual work: 7 Proposals﹒4 Grants
Collaboration Details
Page 1 of 3
Previous page
Next page
10+ Collaborators
$0 / $3.3M Funding
